One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 1months
-
http://medilib.ir
- Duration of Time : 31 Day
Price : 100$- Special Price : 50$
Interaction of heart failure with chronic kidney disease, liver disease and cancer: the need for systems cardiology
Mario Gaudino: New Editor-in-Chief for the European Journal of Cardio-Thoracic Surgery
Genetic counselling implementation in dilated cardiomyopathy: A clinical consensus statement of the Heart Failure Association of the ESC, the ESC Working Group on Myocardial and Pericardial Diseases, and the ESC Council on Cardiovascular Genomics
Heart failure in the elderly: epidemiology, mechanisms, and management
Heart failure and preserved ejection fraction: pathophysiology, clinical assessment, and management of exercise intolerance
Pre-heart failure in early chronic kidney disease: clinical epidemiology and treatment
Reframing cirrhotic cardiomyopathy: a cardiologist’s perspective on an overlooked HFpEF phenotype
Aficamten in symptomatic obstructive hypertrophic cardiomyopathy: the FOREST-HCM long-term study
Long-term safety and efficacy of aficamten in the evolving era of myosin inhibition for obstructive hypertrophic cardiomyopathy
The dual face of lamin A/C cardiomyopathy: risk prediction of heart failure and arrhythmias
Cancer and heart failure: prevalence, incidence, and prognosis in Scotland
Cancer and cardiovascular disease: converging burdens, shared challenges
Cardiac sarcoidosis: new insights beyond the granuloma using spatial proteomics
Resolution of spatiotemporal building blocks in the diagnosis of cardiac sarcoidosis deconvolutes immunopathogenic mechanisms
Nuclear AGO2 exacerbates heart failure with preserved ejection fraction through myocardial ketogenesis
Argonaute nuclear power: nuclear microRNAs control cardiac metabolism in heart failure with preserved ejection fraction
Respiratory syncytial virus infections and myocardial injury: the GEMINI Initiative
Coronary calcifications and myocardial flow reserve in heart transplant patients: a longitudinal study
Questionable metabolic flexibility during cardiac resynchronization therapy
Increased uptake of specific metabolic substrates during cardiac resynchronization therapy despite no change in arterial concentrations: the very definition of metabolic flexibility
Withdrawal of HF therapy in recovered AF-mediated cardiomyopathy: clarifying trial designs
Beyond the map—the challenges and considerations in designing studies exploring uncharted territory
Isolated cardiac mucolipidosis type III α/β mimicking Fabry’s disease: a case report highlighting the role of pathology and genetics in diagnosis
Weekly Journal Scan: Tirzepatide did not SURPASS the cardiovascular benefits of dulaglutide in type 2 diabetes
